Assessing the risk of cervical neoplasia in the <scp>post‐HPV</scp> vaccination era-Reference-Cited by-同舟云学术

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era

Published:2022-10-10 Issue:6 Volume:152 Page:1060-1068
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Lehtinen Matti¹²^ORCID,Pimenoff Ville N.²^ORCID,Nedjai Belinda³,Louvanto Karolina¹⁴,Verhoef Lisanne⁵⁶^ORCID,Heideman Daniëlle A. M.⁵⁶,El‐Zein Mariam⁷,Widschwendter Martin⁸⁹¹⁰¹¹,Dillner Joakim²^ORCID

Affiliation:

1. Medical Faculty Tampere University Tampere Finland

2. Department of Laboratory Medicine Karolinska Institute Stockholm Sweden

3. Wolfson Institute of Population Health Queen Mary University of London London UK

4. Department of Obstetrics and Gynecology Tampere University Hospital Tampere Finland

5. Department of Pathology Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands

6. Cancer Center Amsterdam, Imaging and Biomarkers Amsterdam The Netherlands

7. Division of Cancer Epidemiology McGill University Montreal Canada

8. European Translational Oncology Prevention and Screening (EUTOPS) Institute Universität Innsbruck Hall in Tirol Austria

9. Research Institute for Biomedical Aging Research Universität Innsbruck Innsbruck Austria

10. Department of Women's Cancer, UCL EGA Institute for Women's Health University College London London UK

11. Department of Women's and Children's Health, Division of Obstetrics and Gynecology Karolinska Institute and Karolinska University Hospital Stockholm Sweden

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34286

Reference77 articles.

1. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

2. Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied

3. Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial

4. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

5. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology;Viruses;2024-08-02

2. Estimating HPV16 genome copy number per infected cell in cervical smears;2024-06-14

3. Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16/18 Genotypes;Cancers;2024-05-28

4. Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions;International Journal of Cancer;2024-05-27

5. DNA methylation as a triage tool for cervical cancer screening – A meeting report;Preventive Medicine Reports;2024-05